TET2 and breast cancer: Similarly, TET2 and TET3 expression are increased in peripheral blood mononuclear cells from BC patients compared with healthy donors, suggesting their involvement in the overexpression of immune checkpoint and ligand genes through demethylation of their promoters [47].